Dermatophytic Onychomycosis and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Dermatophytic Onychomycosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatophytic Onychomycosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatophytic Onychomycosis Overall Market Size
2.1 Global Dermatophytic Onychomycosis Market Size: 2021 VS 2028
2.2 Global Dermatophytic Onychomycosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatophytic Onychomycosis Players in Global Market
3.2 Top Global Dermatophytic Onychomycosis Companies Ranked by Revenue
3.3 Global Dermatophytic Onychomycosis Revenue by Companies
3.4 Top 3 and Top 5 Dermatophytic Onychomycosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermatophytic Onychomycosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatophytic Onychomycosis Players in Global Market
3.6.1 List of Global Tier 1 Dermatophytic Onychomycosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatophytic Onychomycosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Dermatophytic Onychomycosis Market Size Markets, 2021 & 2028
4.1.2 Oral Medicine
4.1.3 External Medicine
4.2 By Type - Global Dermatophytic Onychomycosis Revenue & Forecasts
4.2.1 By Type - Global Dermatophytic Onychomycosis Revenue, 2017-2022
4.2.2 By Type - Global Dermatophytic Onychomycosis Revenue, 2023-2028
4.2.3 By Type - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatophytic Onychomycosis Market Size, 2021 & 2028
5.1.2 Age Under 18
5.1.3 Age 18-50
5.1.4 Age Above 50
5.2 By Application - Global Dermatophytic Onychomycosis Revenue & Forecasts
5.2.1 By Application - Global Dermatophytic Onychomycosis Revenue, 2017-2022
5.2.2 By Application - Global Dermatophytic Onychomycosis Revenue, 2023-2028
5.2.3 By Application - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Dermatophytic Onychomycosis Market Size, 2021 & 2028
6.2 By Region - Global Dermatophytic Onychomycosis Revenue & Forecasts
6.2.1 By Region - Global Dermatophytic Onychomycosis Revenue, 2017-2022
6.2.2 By Region - Global Dermatophytic Onychomycosis Revenue, 2023-2028
6.2.3 By Region - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Dermatophytic Onychomycosis Revenue, 2017-2028
6.3.2 US Dermatophytic Onychomycosis Market Size, 2017-2028
6.3.3 Canada Dermatophytic Onychomycosis Market Size, 2017-2028
6.3.4 Mexico Dermatophytic Onychomycosis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Dermatophytic Onychomycosis Revenue, 2017-2028
6.4.2 Germany Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.3 France Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.4 U.K. Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.5 Italy Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.6 Russia Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.7 Nordic Countries Dermatophytic Onychomycosis Market Size, 2017-2028
6.4.8 Benelux Dermatophytic Onychomycosis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Dermatophytic Onychomycosis Revenue, 2017-2028
6.5.2 China Dermatophytic Onychomycosis Market Size, 2017-2028
6.5.3 Japan Dermatophytic Onychomycosis Market Size, 2017-2028
6.5.4 South Korea Dermatophytic Onychomycosis Market Size, 2017-2028
6.5.5 Southeast Asia Dermatophytic Onychomycosis Market Size, 2017-2028
6.5.6 India Dermatophytic Onychomycosis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Dermatophytic Onychomycosis Revenue, 2017-2028
6.6.2 Brazil Dermatophytic Onychomycosis Market Size, 2017-2028
6.6.3 Argentina Dermatophytic Onychomycosis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, 2017-2028
6.7.2 Turkey Dermatophytic Onychomycosis Market Size, 2017-2028
6.7.3 Israel Dermatophytic Onychomycosis Market Size, 2017-2028
6.7.4 Saudi Arabia Dermatophytic Onychomycosis Market Size, 2017-2028
6.7.5 UAE Dermatophytic Onychomycosis Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Dermatophytic Onychomycosis Major Product Offerings
7.1.4 Johnson & Johnson Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Dermatophytic Onychomycosis Major Product Offerings
7.2.4 GSK Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Dermatophytic Onychomycosis Major Product Offerings
7.3.4 Novartis Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Dermatophytic Onychomycosis Major Product Offerings
7.4.4 Pfizer Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 Bausch Health
7.5.1 Bausch Health Corporate Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Dermatophytic Onychomycosis Major Product Offerings
7.5.4 Bausch Health Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.5.5 Bausch Health Key News
7.6 Kaken Pharmaceutical
7.6.1 Kaken Pharmaceutical Corporate Summary
7.6.2 Kaken Pharmaceutical Business Overview
7.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
7.6.4 Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.6.5 Kaken Pharmaceutical Key News
7.7 Galderma
7.7.1 Galderma Corporate Summary
7.7.2 Galderma Business Overview
7.7.3 Galderma Dermatophytic Onychomycosis Major Product Offerings
7.7.4 Galderma Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.7.5 Galderma Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Dermatophytic Onychomycosis Major Product Offerings
7.8.4 Sanofi Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Allergan
7.9.1 Allergan Corporate Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Dermatophytic Onychomycosis Major Product Offerings
7.9.4 Allergan Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.9.5 Allergan Key News
7.10 Merz Pharma
7.10.1 Merz Pharma Corporate Summary
7.10.2 Merz Pharma Business Overview
7.10.3 Merz Pharma Dermatophytic Onychomycosis Major Product Offerings
7.10.4 Merz Pharma Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.10.5 Merz Pharma Key News
7.11 Xiuzheng Pharmaceutical
7.11.1 Xiuzheng Pharmaceutical Corporate Summary
7.11.2 Xiuzheng Pharmaceutical Business Overview
7.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
7.11.4 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.11.5 Xiuzheng Pharmaceutical Key News
7.12 Letai
7.12.1 Letai Corporate Summary
7.12.2 Letai Business Overview
7.12.3 Letai Dermatophytic Onychomycosis Major Product Offerings
7.12.4 Letai Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.12.5 Letai Key News
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Corporate Summary
7.13.2 Qilu Pharmaceutical Business Overview
7.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
7.13.4 Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
7.13.5 Qilu Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Dermatophytic Onychomycosis Market Opportunities & Trends in Global Market
Table 2. Dermatophytic Onychomycosis Market Drivers in Global Market
Table 3. Dermatophytic Onychomycosis Market Restraints in Global Market
Table 4. Key Players of Dermatophytic Onychomycosis in Global Market
Table 5. Top Dermatophytic Onychomycosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dermatophytic Onychomycosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dermatophytic Onychomycosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dermatophytic Onychomycosis Product Type
Table 9. List of Global Tier 1 Dermatophytic Onychomycosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatophytic Onychomycosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dermatophytic Onychomycosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dermatophytic Onychomycosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Dermatophytic Onychomycosis Product Offerings
Table 32. Johnson & Johnson Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Dermatophytic Onychomycosis Product Offerings
Table 35. GSK Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Dermatophytic Onychomycosis Product Offerings
Table 38. Novartis Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Dermatophytic Onychomycosis Product Offerings
Table 41. Pfizer Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Dermatophytic Onychomycosis Product Offerings
Table 44. Bausch Health Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 45. Kaken Pharmaceutical Corporate Summary
Table 46. Kaken Pharmaceutical Dermatophytic Onychomycosis Product Offerings
Table 47. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 48. Galderma Corporate Summary
Table 49. Galderma Dermatophytic Onychomycosis Product Offerings
Table 50. Galderma Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Dermatophytic Onychomycosis Product Offerings
Table 53. Sanofi Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 54. Allergan Corporate Summary
Table 55. Allergan Dermatophytic Onychomycosis Product Offerings
Table 56. Allergan Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 57. Merz Pharma Corporate Summary
Table 58. Merz Pharma Dermatophytic Onychomycosis Product Offerings
Table 59. Merz Pharma Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 60. Xiuzheng Pharmaceutical Corporate Summary
Table 61. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product Offerings
Table 62. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 63. Letai Corporate Summary
Table 64. Letai Dermatophytic Onychomycosis Product Offerings
Table 65. Letai Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
Table 66. Qilu Pharmaceutical Corporate Summary
Table 67. Qilu Pharmaceutical Dermatophytic Onychomycosis Product Offerings
Table 68. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Dermatophytic Onychomycosis Segment by Type in 2021
Figure 2. Dermatophytic Onychomycosis Segment by Application in 2021
Figure 3. Global Dermatophytic Onychomycosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dermatophytic Onychomycosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermatophytic Onychomycosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatophytic Onychomycosis Revenue in 2021
Figure 8. By Type - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 12. US Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 16. Germany Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 24. China Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 30. Brazil Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
Figure 33. Turkey Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Galderma Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Allergan Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merz Pharma Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Letai Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)